Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Other Working Capital Changes (2020 - 2025)

Journey Medical (DERM) has disclosed Other Working Capital Changes for 6 consecutive years, with $674000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Working Capital Changes rose 157.9% year-over-year to $674000.0, compared with a TTM value of $2.3 million through Sep 2025, up 617.3%, and an annual FY2024 reading of -$6000.0, down 102.15% over the prior year.
  • Other Working Capital Changes was $674000.0 for Q3 2025 at Journey Medical, up from $84000.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $2.7 million in Q4 2023 and bottomed at -$1.2 million in Q3 2024.
  • Average Other Working Capital Changes over 5 years is $52684.2, with a median of -$24000.0 recorded in 2021.
  • The sharpest move saw Other Working Capital Changes skyrocketed 214.15% in 2022, then plummeted 3533.33% in 2023.
  • Year by year, Other Working Capital Changes stood at -$827000.0 in 2021, then surged by 214.15% to $944000.0 in 2022, then skyrocketed by 182.2% to $2.7 million in 2023, then fell by 12.16% to $2.3 million in 2024, then tumbled by 71.2% to $674000.0 in 2025.
  • Business Quant data shows Other Working Capital Changes for DERM at $674000.0 in Q3 2025, $84000.0 in Q2 2025, and -$817000.0 in Q1 2025.